Clients covered short sales in exchange-traded funds and scooped up biotech and pharmaceutical stocks, suggesting “little evidence of a broad de-risking or capitulation,” the firm wrote in a note. The …
More Why hedge funds are snapping up shares amidst US healthcare sell-off Videos